Acute diverticulitis occurs in 10–25% of patients with diverticulosis. Colonoscopy is advised 6 weeks after an attack of acute diverticulitis in order to completely evaluate the colonic lumen and exclude a potential malignancy. We conducted several studies aimed to evaluate the feasibility and safety of early colonoscopy in patients with acute diverticulitis. Consecutive patients hospitalized for acute diverticulitis were included. In the first phase of the study, patients with adjacent peri-diverticular air/fluid on CT were excluded. In the second phase of the study, we included patients with peri-diverticular air/fluid on CT as well. During the first phase of the study, 39 patients underwent uneventful colonoscopy. During the second phase of the study, 40 patients underwent colonoscopy and 1 of 6 patients with peri-diverticular air had perforation of her sigmoid colon. Two patients had a more protracted course and were clearly those who benefited most from the early colonoscopy. Based on our study, we concluded that early colonoscopy in acute diverticulitis is feasible. It should be reserved either for all patients with no air adjacent to diverticuli on CT or just for those with a more protracted course. In the third phase, a prospective randomized study was conducted on patients with acute diverticulitis with no peri-diverticular air. Such patients were randomized into those who underwent early colonoscopy and those who underwent colonoscopy 6 weeks later. Eighty-three patients were included in both groups and in none has a significant lesion been identified (except polyps). It seems therefore that the current abdominal CT with its excellent resolution is enough to exclude colonic cancer. Colonoscopy should be reserved only for patients with a protracted unresolved course of acute diverticulitis.

1.
Brewster NT, Grieve DC, Saunders JH: Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg 1994;81:445–447.
2.
Cawthorn SJ, Gibbs NM, Marks CG: Segmental colitis: a new complication of diverticular disease. Gut 1983;24:A500.
3.
Tursi A, Elisei W, Brandimarte G, et al: The endoscopic spectrum of segmental colitis associated with diverticulosis. Colorectal Dis 2010;12:464–470.
4.
Tursi A, Elisei W, Giorgetti GM, et al: Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Aliment Pharmacol Ther 2011;33:358–365.
5.
Hale WB, NDSG: Colonoscopy in the diagnosis and management of diverticular disease. J Clin Gastroenterol 2008;42:1142–1144.
6.
Freeman HJ: Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome). Dig Dis Sci 2008;53:2452–2457.
7.
Parks TG: Natural history of diverticular disease of the colon. Clin Gastroenterol 1975;4:53–69.
8.
Halphen M, Blain A: Natural history of colonic diverticulosis. Rev Prat 1995;45:952–958.
9.
Jacobs DO: Clinical practice: diverticulitis. N Engl J Med 2007;15;357:2057–2066.
10.
Sakhnini E, Lahat A, Melzer E, Apter S, Simon C, Natour M, Bardan E, Bar-Meir S: Early colonoscopy in patients with acute diverticulitis: results of a prospective pilot study. Endoscopy 2004;36:504–507.
11.
Lahat A, Yanai H, Menachem Y, Avidan B, Bar-Meir S: The feasibility and risk of early colonoscopy in acute diverticulitis: a prospective controlled study. Endoscopy 2007;39:521–524.
12.
Lahat A, Yanai H, Sakhnini E, Menachem Y, Bar-Meir S: Role of colonoscopy in patients with persistent acute diverticulitis. World J Gastroenterol 2008;14:2763–2766.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.